MT
CRL icon

Midwest Trust’s Charles River Laboratories CRL Stock Holding History

Midwest Trust’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.09M Sell
26,858
-52
-0.2% -$9.26K 0.07% 199
2026
Q1 		$4.64M Buy
26,910
+28
+0.1% +$5.19K 0.06% 217
2025
Q4 		$5.36M Sell
26,882
-165
-0.6% -$29.9K 0.07% 205
2025
Q3 		$4.23M Buy
27,047
+906
+3% +$144K 0.06% 222
2025
Q2 		$3.97M Buy
+26,141
New +$3.49M 0.05% 222

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Midwest Trust's CRL Position: Q2 2026 in Review

Midwest Trust reduced its Charles River Laboratories (CRL) stake by 0.19% in Q2 2026, selling an estimated $9.26K and leaving 26,858 shares worth $6.09M. The position accounts for 0.07% of the portfolio, ranked #199.

Midwest Trust first reported a position in CRL in Q2 2025 and has held it in 5 quarters since. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Midwest Trust held 26,858 shares of Charles River Laboratories worth $6.09M as of Q2 2026.
  • Midwest Trust sold 52 Charles River Laboratories shares in Q2 2026, an estimated $9.26K.
  • Charles River Laboratories made up 0.07% of Midwest Trust's portfolio in Q2 2026, its #199 holding.
  • Midwest Trust first reported a position in Charles River Laboratories in Q2 2025 and has held it in 5 quarters since.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Midwest Trust's 13F filing for Q2 2026, filed 5 Aug 2026.